1. Home
  2. TBI vs KRRO Comparison

TBI vs KRRO Comparison

Compare TBI & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrueBlue Inc.

TBI

TrueBlue Inc.

HOLD

Current Price

$4.59

Market Cap

129.9M

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$13.89

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBI
KRRO
Founded
1985
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.9M
150.0M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
TBI
KRRO
Price
$4.59
$13.89
Analyst Decision
Buy
Buy
Analyst Count
1
12
Target Price
$6.00
$34.80
AVG Volume (30 Days)
305.8K
171.5K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
61.39
N/A
EPS
N/A
N/A
Revenue
N/A
$6,392,000.00
Revenue This Year
$6.25
N/A
Revenue Next Year
$3.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
181.46
52 Week Low
$3.18
$5.20
52 Week High
$7.78
$55.89

Technical Indicators

Market Signals
Indicator
TBI
KRRO
Relative Strength Index (RSI) 65.84 57.22
Support Level $4.57 $12.98
Resistance Level $5.56 $15.00
Average True Range (ATR) 0.29 1.02
MACD 0.12 0.04
Stochastic Oscillator 93.24 50.34

Price Performance

Historical Comparison
TBI
KRRO

About TBI TrueBlue Inc.

TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: